Globe Life Inc. Issues Statement Refuting Short Seller Allegations

Go back to Globe Life Inc. Issues Statement Refuting Short Seller Allegations

CFRA Downgrades Globe Life (GL) to Sell

April 12, 2024 12:05 PM EDT

CFRA analyst Catherine Seifert downgraded Globe Life (NYSE: GL) from Hold to Sell with a price target of $55.00 (from $63.00).

The analyst comments "We cut our 12-month target price by $63 to $55. Our revised target price values the shares at 4.8x our 2024 operating EPS... More

KBW on Globe Life (GL): 'Sell-Off Likely Way Overdone, but Near-Term Uncertainty Remains'

April 12, 2024 6:04 AM EDT

Keefe, Bruyette & Woods analyst Ryan Krueger reiterated a Market Perform rating and $130.00 price target on Globe Life (NYSE: GL)

The analyst comments "GL sold-off -53% following a short report from Fuzzy Panda Research alleging widespread insurance fraud within American Income (AIL), which follows... More

Globe Life (GL) PT Lowered to $75 at Evercore ISI

April 12, 2024 4:30 AM EDT

Evercore ISI analyst Thomas Gallagher lowered the price target on Globe Life (NYSE: GL) to $75.00 (from $125.00) while maintaining a In Line rating.

The analyst comments "This morning, Fuzzy Panda Research published a scathing short selling report on GL, accusing the firm of agent mis-selling practices, insurance fraud, aggressive accounting, a distribution pyramid scheme, and an overall toxic workplace environment. With the recent disclosure that the DOJ has issued a subpoena to the company to investigate some of these allegations, we think this has created significant uncertainty for the shares as demonstrated by... More